It was found that KDM6B can inhibit breast cancer metastasis by regulating the Wnt/β-linked protein signaling pathway [16]; while in ovarian cancer, KDM6B promotes cancer cell migration and invasion by inducing the expression of transforming growth factor β1 [17]. Here, KDM6B is linked to ovarian carcinoma.